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Abstract
A compound was specifically designed to further aid research on the detection and treatment
of folate receptor positive cancer cells. A small but complex peptide chain was commercially
produced to have a flexible glycine spacer and a six-histidine tag. Histidine tagging was chosen
for its ability to bind to nickel. The compound in this report was purified and analyzed by HPLC
and confirmed via mass spectrometry. This binding capacity and the ability of folate conjugates
to bind to cancer cell receptors have both been explored for the past quarter of a century [13]. Folate conjugates have been successfully used as a transporter of cytotoxins and imaging
agents through folate receptors (FRs), while histidine tagging has been used for imaging with
dyes, separation, and purification with columns and metallic beads [4-14].
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Introduction
Biochemists are constantly using life’s essential molecules for medical treatments and
research. Both vitamin B (folic acid) and histidine are two essential compounds that the human
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body must ingest [2, 12, 14]. The combination of these two compounds with a synthesis reaction
may have important applications for treating malignant cells and eventually cancer patients, and
the applications of this new compound should continue to be explored. There is hope that this
new compound can be used for the detection and even capture of malignant cells with little
adverse effects on the patient.
Numerous factors went into designing the specific EGGHHHHHH peptide, shown in figure
1. The fact that it is a peptide makes it unlikely to cause harm to surrounding tissue in the
body. The chosen peptide was also found at an affordable price and is readily available. This
commercially manufactured peptide resin was created for several reasons. Specifically, the
histidine tags have the ability to bind with nickel chelators and the glutamic acid and glycine
were also specifically chosen to form a spacer. The folate compound is also often connected to
polyethelyene glycol (PEG) to provide flexibility and expand the uses for folate conjugates [2, 5,
9]. Glycine is a flexible amino acid that is intended to be used as a spacer to aid in the delivery
of the entire molecule.
Histidine is a unique amino acid that tends to bind to metals, and has an especially strong
affinity towards nickel. For this reason, it has been used in ion chromatography as well as
several separation and purification methods with the use of chelating agents [5]. Poly-histidine
tagging entails attaching a chain of at least six histidine peptides to the N or C terminus of a
protein or a peptide for attachment to a folate conjugate [6]. A six-histidine strand is the
standard chain used for tagging, however, longer strands—a ten or fourteen histidine chain—
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have increased bonding and can provide more definitive results due to their significant affinity
[6]. Histidine tags only rarely interfere with protein’s function, and are a versatile tool for a wide
range of protein purification purposes [15]. Histidine tagging has also been utilized in the
medical field as a biomarker for cardiovascular disease [16].
A common chelating agent is nickel combined with nitrilotriacetic acid (Ni-NTA), which is
used in many different processes. The Ni-NTA beads are used for the purification and separation
of peptides and proteins with immobilized metal affinity chromatography. Ni-NTA is also
applied to nano-particles and dyes that are better suited for diagnostic techniques. The dye still
provides a simple method to determine if the compound was synthesized correctly and still has
the function of a typical histidine tag molecule and can bring imaging agents to the target. Not
only are the Ni-NTA compounds versatile but they have little to no effect on surrounding
proteins or cells [17]. If this chelating agent does not work in vivo, there are several modified
versions available [6, 7].
FRs have four different isomers: FR-α, FR-β, FR-γ, and FR-δ. FR-α and FR-β are
glycosylphosphatidylinositol-anchored membrane-bound receptors that are necessary for DNA
replication and single carbon pathways. The intake of folic acid and cofactors in a macrophagic
manner with high affinity mediates the cellular uptake of this vitamin, and drug conjugates
thereof, via receptor-mediated endocytosis [14, 18]. The significance of this receptor as a tumor
marker was discovered in 1991 when the amino acid sequence analysis of a protein enriched on
the surface of a human ovarian carcinoma cell line was shown to be the FR [12].
FR-β are generally found in hematopoietic tissues, macrophages, and fetal brain tissues. FR-γ
are found in hematopoietic tissues and FR-δ are regulatory T-cells which travel throughout the
body to fight infection, but neither have an affinity for absorbing folic acid at the same rate.
5

Folate conjugates have well-known interactions with folate receptors and have the ability to
identify and attack malignant cells with folate cofactors attached to chemotherapeutics and
imaging agents. Exploiting the fact that many cancers overexpress FRs (whereas most normal
tissues express low to negligible levels) has proved to be of clinical significance, particularly
regarding the current development of folate-targeted imaging and therapeutic agents [12]. These
receptors are rarely found on healthy human cells outside the kidney, liver or bone marrow. The
overexpression of FRs in malignant tissues provides a selectivity of toxicities to pathologic cells,
thereby avoiding damage that accompanies the uptake by healthy cells [12].
Being able to produce a compound that can combine these technologies will open many new
opportunities in biomedical research. Further testing is necessary to see if such a complex
peptide can be absorbed into malignant cells in the same way as other FR targeting molecules
employed in the past. In sum, the versatility of the histidine tag in the cell may be the next
revolution in folate conjugate research.
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Folate Peptide Synthesis
A one-step synthesis was conducted to conjugate the EGGHHHHHH peptide and folate..
Chemicals reagents; 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3oxid hexafluorophosphate, N-[(Dimethylamino)-1H-1,2,3-triazolo-[4,5-b]pyridin-1ylmethylene]-N-methylmethanaminium hexafluorophosphate N-oxide (HATU), and 99%
Diisopropylamine (DIPEA), Trifluoroacetic acid (TFA), triisopropylnaphthalenesulfonic acid
sodium salt (TIPS), a 30 mL stock of dimethylformamide (DMF), and a stock of 20% piperidine
in DMF solution made with 8 mL of DMF and 2 mL of piperidine were used to complete the
synthesis. The peptide was prepared commercially by Peptide 2.0 (Chantilly, VA). All other
reagents were purchased from Sigma/Aldrich (St. Lois, MO).
40.06 mg of resin was placed in a 3 mL peptide synthesis syringe then rinsed three times with
3 mL of DMF. An additional 3 mL of DMF was added to the syringe and it was placed on a
digital vortex for mixing for 15 minutes, which allowed the resin to swell. Once the DMF was
removed, 2 mL of the 20% piperidine was then added and placed back on the vortex three times
for five minutes each. The piperidine was used to remove the Fmoc from our peptide. The resin
was then ready for the addition of the pteroic acid, which attached a folate molecule to the
peptide. The resin was then washed six times with the remainder of the DMF.
Meanwhile, a new vial containing 25.0 mg of pteroic acid was opened and 37.9 mg HATU
was added followed by 22 mL of DIPEA. The contents of the vial were drawn into the syringe,
and the syringe was then wrapped in parafilm and placed on the digital vortex overnight to insure
the reaction was accomplished. The resin was then cleaved with 95% TFA, 2.5% TIPS and
water, and precipitated in cold diethyl ether. The newly synthesized compound needed to be
evaluated with high performance liquid chromatography/mass spectrometry (HPLC/MS) to
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determine if it was produced properly. After verification of the molecule, the investigation of the
applications of this new compound are soon to follow.
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High Performance Liquid Chromatography Analysis
The HP 1050 HPLC was used both for the analysis and purification of the synthesized
compound. The diode array detection (DAD) of folate’s known absorption pattern, with a sharp
peak at 280 nm and a broad peak around 360 nm, was easily identified. Verification that the
compound was synthesized successfully was performed, and an evaluation with HP 1050 HPLC
was conducted to assure us that our compound was created without errors. A 5µL sample was
injected into a reverse phase analytical column (Phenomenex 00G-4041-E0 Luna 5u C18
250x4.60 mm 5u micron 209 201-8). A single strong peak was found at 24.75 min during the
HPLC separation. Figure 2 illustrates that the compound has been produced with little
impurities. The DAD spectra shown in figure 3 was produced by our compound and matches
the expected folate conjugate pattern. A 100 µL sample was then purified with the purification
column Rigel 5µm C18 10x250 mm cat # 5c18-10-250 (column serial # 9-122A). The
compound was dried with nitrogen gas to remove any remaining ammonia and a large sample
was ready to be analyzed with MS.
The method for the analysis employed of a 0.1 nM ammonium bicarbonate buffer and
acetonitrile is typically used for folate conjugates. However, due to the fact that histidine amino
acids can easily become protonated, causing separate retention times, hydrochloric acid was
added to the bicarbonate buffer to adjust it from pH 7.7 to pH 4.5 in order to prevent the peaks
from splitting. The runs were performed at 1.0 ml/min starting with a 99% ammonium buffer,
changing to 70% at 30 minutes, at which time the compound had already been eluted.
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Mass spectrometry analysis
The folate histidine compound’s exact mass was calculated from chemdraw in figure 1, and
was determined to have a mass of 1377.54 amu. The peak for the singly protonated compound
has a m/z of 1378.54 and several informative peaks were expected to be found for the double
(m/z=679.77), triply (m/z=460.18), and quadrupole (m/z=345.39) protonated molecules.
The instrument employed was Argilent 1260 MSD XCT trap, and the parameters were set as
follows: nebulizer at 40.0 psi, dry gas at 8.0 l/min, and dry temp at 300.0o C. The sample was
initially injected directly into the MS for positive ionization and analysis, producing figure 4. A
second run was performed after maintenance using the HPLC’s auto sampler without a column,
producing figure 5.
Both runs produced several peaks representing multiply charged species. Figure 5 shows
strong peaks for the singly, doubly and triply charged molecules, while figure 4 contains the
quadruple charged peak but not the singly charged. Due to the wide range of these peaks and the
instruments used, all of the peaks could not be displayed on one mass spectrum. For these runs,
the peaks were within the instrument’s normal error of m/z=0.5. This data clearly shows that
the compound of interest was successfully synthesized.
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Conclusion
The synthesis was completed successfully and verified with HPLC/MS. The purchase of a
commercially manufactured peptide EGGHHHHHH resin provided a quick and affordable
method of advancing studies in the field of folate targeting research. Due to the price of the
peptide, alterations or the purchase of another peptide with different spacers or additional
histidine, where necessary, can be an efficient way to continue research.
The development of a compound to be used in humans is a long and tedious process. In this
research, a new compound was attached to a FR targeting molecule. The synthesis was verified
with analytical procedures. Further extensive testing is required, however, to see if and what the
synthesis can provide for medical research and treatment. Many steps and requirements will
need to be passed before this molecule can be employed in the treatment of cancer. In particular,
the Ni-NTA dyes will need to be investigated and their interactions with malignant cells are the
next step.
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Attached figures
Figure 1:

The structure of the synthesized molecule was drawn with Chemdraw Ultra 12 and is shown above. The
software was used to determine the mass of the compound of 1377.54 amu. This mass was then used to
verify that the molecule was synthesized correctly using mass spectrometry. The figure also shows the
separate moieties of the compound.
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Figure 2:
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The chromatogram shows a single peak at 24.20 min. This indicates that there is a single compound with
no impurities remaining in solution.
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Figure 3:

The diode array detector (DAD) produced during the analysis and purification of the compound shows a
strong absorption at 280 nm and a broad peak at 360 nm. This is a sign that the compound being eluted
contains folate moieties.
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Figure 4:

The doubly, triply, and quadruple charged molecules can easily be found on this spectrum (at m/z= 689.9,
460.5, and 345.9 respectively). This shows better resolution of the molecule with more charges but loses
some accuracy.
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Figure 5:

In this spectrum, the singly, doubly and triply charged molecules can easily be found (at m/z= 1378.7,
690.4, and 461.0 respectively).
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